Growth Metrics

Dare Bioscience (DARE) Receivables - Net (2016 - 2024)

Dare Bioscience's Receivables - Net history spans 9 years, with the latest figure at $700000.0 for Q4 2024.

  • For Q4 2024, Receivables - Net changed N/A year-over-year to $700000.0; the TTM value through Dec 2024 reached $700000.0, changed N/A, while the annual FY2024 figure was $700000.0, N/A changed from the prior year.
  • Receivables - Net reached $700000.0 in Q4 2024 per DARE's latest filing, down from $10.0 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $49.0 million in Q2 2021 to a low of $12000.0 in Q4 2020.
  • Average Receivables - Net over 4 years is $8.6 million, with a median of $428000.0 recorded in 2020.
  • Peak YoY movement for Receivables - Net: surged 29241.32% in 2021, then tumbled 79.59% in 2022.
  • A 4-year view of Receivables - Net shows it stood at $12000.0 in 2020, then skyrocketed by 408233.33% to $49.0 million in 2021, then crashed by 79.59% to $10.0 million in 2022, then tumbled by 93.0% to $700000.0 in 2024.
  • Per Business Quant, the three most recent readings for DARE's Receivables - Net are $700000.0 (Q4 2024), $10.0 million (Q2 2022), and $49.0 million (Q2 2021).